Hyperinflammatory diseases and several autoimmune diseases are linked to pathogen infections, but the pathogenesis remains elusive. A hyperinflammatory and autoimmune disease pathogenesis theory should explain how several pathogens can cause numerous distinct hyperinflammatory and autoimmune diseases
Virulent pathogen infections can cause lymphocyte exhaustion and/or suppression [1]. Some virulent pathogen infections can cause multiple lymphocyte exhaustions and/or suppressions of immune cells, including natural killer NK-cells and thymic T-cells [1]. Lymphocyte suppression has several causes. Known causes include tissue hypoxia (reduced oxygen levels); neuroendocrine activations (e.g., glucocorticoids); hypercoagulable blood states (e.g., increased tissue factor, fibrin, thrombin and platelet activation); pro-inflammatory prostaglandins (e.g., prostaglandin E2); interleukin-6 (IL-6), anti-inflammatory phase factors including interleukin-10 (IL-10) and transforming growth factor-β1 (TGF-β1), regulatory T-cells or myeloid-derived suppressor cells (MDSCs) [2, 3].
T-cell exhaustion, bone marrow B-cell and NK-cell exhaustion include inhibited functionalities and proliferation caused by continuous antigen stimulation resulting from chronic infections or cancers [3]. Lymphocyte exhaustion over time can become almost irreversible, unlike suppression, which can be reversible [3].
A theory for hyperinflammatory disease and vasculitis-associated autoimmune disease pathogenesis follows. This involves exhaustion and/or suppression of lymphocytes, including NK-cells, T-cells and/or B-cells, where lymphocyte exhaustion and/or suppression can potentially be involved in up to three distinct pathogenesis steps. This theory applies to individuals having transient or permanent immuno-deficiencies (e.g., complement deficiencies) in their antigen–antibody immune complex phagocytosis abilities [4].
Very high titers of antigen–antibody immune complexes can result from a relatively quick pathogen-induced lymphocyte exhaustion and/or suppression that enables high replication rates for pathogens and their antigens [4]. This is the first lymphocyte exhaustion and/or suppression involvement, involving cytolytic NK-cells and/or T-cells targeting pathogen-infected cells.
A quick lymphocyte exhaustion and/or suppression is important in the next step, due to the time follicular helper CD4+ T-cells require to assist B-cells in developing more effective antibodies by affinity maturation and isotype switching to target novel pathogen antigens produced from a first-time virulent pathogen infection [5]. This is the second potential lymphocyte exhaustion and/or suppression involvement, involving follicular helper CD4+ T-cells. Either this involvement, or alternatively impaired B-cells, can result in ineffective antibodies, ultimately creating very high titers of antigen–antibody immune complexes. The alternative path without follicular helper CD4+ T-cell exhaustion could involve B-cells, impaired from a previous B-cell pathogen infection (e.g., a herpesvirus) or another cause of B-cell dysfunction, secreting ineffective antibodies [3].
Very high titers of antigen–antibody immune complexes will initiate a Type III hypersensitivity immune reaction, resulting in increased populations of activated T-cells and other activated immune cells which will secrete a variety of proteinases that express or expose a variety of autoantigens while cleaving host proteins [4]. However, if immunoregulatory NK-cells and/or regulatory T-cells are also exhausted and/or suppressed in their ability to reduce populations of activated T-cells and other activated immune cells, the proteinase-created autoantigens will continue to autoantigen-activate T-cells and other immune cells to release more proteinases to autoantigen-activate more T-cells and other immune cells [6, 7]. This is the third potential lymphocyte exhaustion and/or suppression involvement, involving immunoregulatory NK-cells and/or regulatory T-cells.
This theory can explain how multiple pathogens cause several specific inflammatory diseases. For example, resulting blood vessel endothelial cell inflammation can exhibit vasculitis [4]. If the individual’s immune system impairment is temporary, a transient hyperinflammatory disease occurs; if not, a chronic vasculitis-associated autoimmune disease (e.g., systemic lupus erthematosus, rheumatoid arthritis, or other disease) occurs. Homeostasis restoration may require regulatory T-cells, immunoregulatory NK-cells, MDSCs, proteinase inhibitors and/or other agents.
Ineffective antibodies result from impaired follicular helper CD4+ T-cells, located in lymph node and spleen germinal centers [5]. Follicular helper CD4+ T-cells are crucial for antibody affinity maturation, isotype switching, memory B-cell creation and B-cell differentiation into immunoglobulin (antibody) secreting plasma cells [5]. Follicular helper CD4+ T-cell exhaustion is possible and would impair effective antibody production [5]. Consequently, novel infections by a virulent pathogen (e.g., SARS-CoV-2 virus) will be difficult to suppress due to quantitatively and/or qualitatively inadequate immunoglobulins (antibodies) secreted by B-cells and plasma cells [5].
Recent observations of SARS-CoV-2 virus infections provide supportive evidence. Severe COVID-19 patients exhibit ineffective B-cells, and these patients have higher population fractions of less-developed membrane-bound IgM immunoglobulin on B-cells, compared to higher population fractions of more developed membrane-bound IgG immunoglobulins on B-cells seen in control patients [10]. These immunoglobulin isotype differences suggest T-cell exhaustion or suppression of germinal center follicular helper CD4+ T-cells impaired B-cell isotype switching and somatic hypermutation affinity maturation of immunoglobulins targeting the SARS-CoV-2 virus [5, 10].
The SARS-CoV-2 virus ability to induce both NK-cell exhaustion and T-cell exhaustion impairs the immune system’s capability to inhibit replication of SARS-CoV-2 virus [1], and increased SARS-CoV-2 virus replication will cause higher antigen and antigen–antibody immune complex titers [10].
COVID-19-associated hyperinflammatory disease multisystem inflammatory syndrome (MIS) provides evidence of concurrent T-cell exhaustion and immunoregulatory NK-cell exhaustion [8, 9]. Immunoregulatory NK-cell and autoantigen-activated T-cell involvements in autoimmune diseases are also documented [6, 7].
In conclusion, a theory is proposed involving individuals having transiently or permanently induced immuno-deficiencies in phagocytizing high titers of antigen–antibody immune complexes. Very high titers of antigen–antibody immune complexes can result from pathogen-induced lymphocyte exhaustion and/or suppression, enabling high pathogen and antigen replication rates. A quick-paced exhaustion and/or suppression is probably involved, quicker than the necessary time required for follicular helper CD4+ T-cells to assist B-cells in developing and secreting more effective antibodies by affinity maturation and isotype switching to bind antigens produced from a first-time pathogen infection. The result is very high titers of antigen–antibody immune complexes. Very high titers of antigen–antibody immune complexes will initiate a Type III hypersensitivity immune reaction, producing increased populations of activated T-cells and other activated immune cells, releasing proteinases that express or expose various autoantigens from cleaving host proteins. However, if immunoregulatory NK-cells and/or regulatory T-cells are also exhausted and/or suppressed, they will not control activated T-cells and other activated immune cell populations, and autoantigens will continue to autoantigen-activate more T-cells and other immune cells that release more proteinases that autoantigen-activate more T-cells and other immune cells. If an individual’s immune system impairment is temporary, a transient hyperinflammatory disease occurs. If homeostasis cannot be restored, a chronic autoimmune disease occurs. Hyperinflammatory diseases and/or vasculitis-associated autoimmune diseases can result from multiple lymphocyte exhaustion and/or suppression induced by pathogen infections, also including impairment of immunoregulatory lymphocytes or other agents that would otherwise control or prevent these diseases.
Supplementary Information
Below is the link to the electronic supplementary material.
Author contribution
No other author contributed to this paper.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Data availability
Not applicable.
Declarations
Conflict of interests
None.
Permission to reproduce
Not applicable.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, Xu Y, Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533–535. doi: 10.1038/s41423-020-0402-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Market M, Tennakoon G, Auer RC. Postoperative Natural Killer Cell Dysfunction: The Prime Suspect in the Case of Metastasis Following Curative Cancer Surgery. Int J Mol Sci. 2021;22(21):11378. doi: 10.3390/ijms222111378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Roe K. NK-cell exhaustion, B-cell exhaustion and T-cell exhaustion—the differences and similarities. Immunology. 2022;166(2):155–168. doi: 10.1111/imm.13464. [DOI] [PubMed] [Google Scholar]
- 4.Roe K. Explanations for 10 of the most puzzling aspects of multisystem inflammatory syndrome and other Kawasaki-like diseases. J Clin Pharm Ther. 2022;47(4):539–543. doi: 10.1111/jcpt.13560. [DOI] [PubMed] [Google Scholar]
- 5.Cavazzoni CB, Hanson BL, Podestà MA, Bechu ED, Clement RL, Zhang H, Daccache J, Reyes-Robles T, Hett EC, Vora KA, Fadeyi OO, Oslund RC, Hazuda DJ, Sage PT. Follicular T cells optimize the germinal center response to SARS-CoV-2 protein vaccination in mice. Cell Rep. 2022;38(8):110399. doi: 10.1016/j.celrep.2022.110399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Galazka G, Domowicz M, Ewiak-Paszynska A, Jurewicz A. NK cell induced T cell anergy depends on GRAIL expression. Cells. 2019;8(8):790. doi: 10.3390/cells8080790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gross CC, Schulte-Mecklenbeck A, Rünzi A, Kuhlmann T, Posevitz-Fejfár A, Schwab N, Schneider-Hohendorf T, Herich S, Held K, Konjević M, et al. Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation. Proc Natl Acad Sci USA. 2016;113:E2973–E2982. doi: 10.1073/pnas.1524924113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Huang JJ, Gaines SB, Amezcua ML, Lubell TR, Dayan PS, Dale M, Boneparth AD, Hicar MD, Winchester R, Gorelik M. Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome. J Allergy Clin Immunol. 2022;149(3):912–922. doi: 10.1016/j.jaci.2021.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rey-Jurado E, Espinosa Y, Astudillo C, Jimena Cortés L, Hormazabal J, Noguera LP, Cofré F, Piñera C, González R, Bataszew A, Muñoz Venturelli P, Benadof D, Álvarez P, Acevedo V, Vial P, Vial C, Poli MC. Deep immunophenotyping reveals biomarkers of multisystemic inflammatory syndrome in children in a Latin American cohort. J Allergy Clin Immunol. 2022;150(5):1074–1085.e11. doi: 10.1016/j.jaci.2022.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Rendeiro AF, Casano J, Vorkas CK, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K, Brown CD, Hsu J, Kyriakides C, Chiu S, Cappelli LV, Cacciapuoti MT, Tam W, Galluzzi L, Simonson PD, Elemento O, Salvatore M, Inghirami G. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Life Sci Alliance. 2020;4(2):202000955. doi: 10.26508/lsa.202000955. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Not applicable.
